Hologic, Inc. vs Merck & Company, Inc. — Stock Comparison

HOLX
Hologic, Inc.
$76.01
vs
MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
Q·Score Winner
Merck & Company, Inc.
MRK6.7/10vs 6.1/10

Q·Score Breakdown

6.1
Neutral
Overall
6.7
Neutral
7
Quality
6.2
9.2
Health
7
4.4
Growth
6.2
6.5
Valuation
7.2
2.5
Sentiment
7.1
HOLX

Clean balance sheet with low leverage (0.5× debt-to-equity).

cautious analyst consensus — few Buy ratings.

MRK

Forward P/E of 11.5× is low relative to sector peers.

Analyst Consensus

HOLD
Target $76.67 (+0.9%)
9 analysts
BUY
Target $129.74 (+15.7%)
27 analysts

Fundamentals

HOLX
MRK
31.5×
Trailing P/E
31.5×
15.6×
Forward P/E
11.5×
13.2%
Profit Margin
13.6%
60.4%
Gross Margin
76.6%
10.9%
ROE
2.5%
Revenue Growth
4.9%
-9.2%
Earnings Growth
0.70
Beta
0.28
Price / Book
$17.0B
Market Cap
$277.0B
$52 – $76
52-Week Range
$73 – $125

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →